iPSC Seminars: Early Drug Discovery Unit (EDDU) (Virtual)

Thursday, May 25, 2023 11:00to12:00
Montreal Neurological Institute 3801 rue University, Montreal, QC, H3A 2B4, CA

To register: LINK

(The event will be taking place over Zoom)

Drug screen in iPSC-Neurons identifies nucleoside analogs as inhibitors of (G4C2)n expression in C9orf72 ALS/FTD.
Ashutosh Dhingra, Ph.D.
German Center for Neurodegenerative Diseases (DZNE)-Tübingen

Targeting miR-22-3p to enhance GBA1 levels and GCase activity in iPSC-derived models of Parkinson’s disease.
Anelya Gandy
The Neuro's Early Drug Discovery Unit (EDDU), Canada

Supported by Healthy Brains for Healthy Lives and STEMCELL Technologies, The Neuro's iPSC Seminar Series welcomes trainees and senior scientists working with induced pluripotent stem cells (iPSCs) to present their cutting-edge research. The Seminar Series intends to foster collaborations within the network of laboratories working with iPSCs in Montreal, Canada, and around the world. Who should attend: research staff and trainees.

Event coordinators: Rina Shlaifer and Luisa Pimentel

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates


The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.



Facebook instagram x, formerly known as twitter linkedIn youtube

Back to top